Podcast appearances and mentions of angela rasmussen

Éric Blais, President of Headspace Marketing in Toronto, joins host Vassy Kapelos to discuss how advertisements impact an election campaign, and to help break down the strategy behind each parties choice of advertisement. On todays show: Mike Le Couteur, Senior Political Correspondent, CTV National News, Abigail Bimman, CTV News Correspondent and Rachel Aiello, CTV National News Correspondent join host Vassy Kapelos for the latest from the campaign trail. Listen to Vassy's full conversation with Perry Bellegarde, Former National Chief of the Assembly of First Nations as they discuss the passing of Pope Francis and how his papacy is being viewed by Indigenous communities. Vassy Kapelos hosts ‘The Daily Debrief’ political panel discussion with Shakir Chambers, principal at Earnscliffe Strategies, Shachi Kurl, president of the Angus Reid Institute, and Sabrina Grover, Sr Advisor, Spark Advocacy and NorthStar Public Affairs. Dr. Angela Rasmussen, Virologist, and Principal Research Scientist, Vaccine and Infectious Disease Organization at the University of Saskatchewan joins host Vassy Kapelos to discuss the increased fear of the bird flu becoming a possible pandemic as now it may pose a growing risk to people as the pathogen spreads.

GUEST Dr. Angela Rasmussen on bird flu and flu season // Port Angeles welcomes Canadians // SCENARIOS!

During 2024, the average price of a dozen large, Grade A eggs jumped 65 percent. The USDA predicts prices will go up another 20 percent this year. A big reason for these sky-high prices: the bird flu outbreak that started in 2022. John Yang speaks with livestock economist David Anderson and virologist Angela Rasmussen for more. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Youth Climate Activists Score A Win In MontanaThis week, a state court in Montana ruled in favor of a group of 16 youth climate activists, who argued that a state environmental law was in violation of a provision in the state constitution. The Montana constitution states: “The state and each person shall maintain and improve a clean and healthful environment in Montana for present and future generations.”  The ruling will allow (but not require) regulators to consider climate impacts when evaluating proposed energy projects for approval.Umair Irfan, staff writer at Vox, joins Ira to talk about the decision and what it might mean for other climate-related litigation around the country. They'll also discuss other science news of the week, including some strange particle physics from Fermilab,  the end of the road for the common incandescent light bulb, and how researchers decoded a snippet of song — using electrodes on a brain. COVID-19's Summer Wave Raises New QuestionsStep outside into a public place, and you may experience some deja-vu: Masking is back up, the coughs and sniffles are echoing, and coworkers are calling in sick. It's not just your imagination—hospitalizations from COVID-19 are up 14.3 percent for the week of August 5. This new wave has a name: EG. 5, named for the recent Omicron variant that is now the most prevalent.With new boosters on the horizon, Ira catches up with Dr. Angela Rasmussen, virologist at VIDO, the Vaccine and Infectious Disease Organization, at the University of Saskatchewan. They answer questions about the new monovalent booster, testing guidance, and why COVID-19 is still a public health problem.New Research Suggests Neurological Culprit For COVID Brain FogAmong the most debilitating symptoms of Long Covid is brain fog, a condition which includes symptoms like confusion or inability to concentrate. A recently published study using mice cells in petri dishes suggests that brain fog might be the result of neurons fusing together. The results have yet to be tested in live animals or humans. SciFri producer Kathleen Davis talks with study author, Dr. Ramón Martínez-Mármol, research fellow at the Queensland Brain Institute, at the University of Queensland, based in Brisbane, Australia, about what his research might help us better understand about brain fog. Reno Is Preparing To Turn Its Wastewater Into Drinking WaterInside a water treatment plant in north Reno, Nev., on a recent Wednesday, recycled wastewater was running beneath a floor grate inside a small testing room. Inside the space is a system of serpentine-like PVC pipes with 19 different ports, used to test water samples at different intervals.“It's about halfway through the treatment process at the wastewater facility,” said Lydia Teel, an engineer with the Truckee Meadows Water Authority, or TMWA, which serves about 440,000 people in the greater Reno area. “So, it's clean, but there's still some color, there's bacteria in it, some solids.”Teel spearheads a demonstration project called OneWater Nevada, an effort to show that the region can recycle the water that flushes down people's toilets and shower drains and – eventually – turn it back into clean, pure drinking water flowing from faucets, effectively creating a new water resource. The project is a collaboration between TMWA, the cities of Reno and Sparks, the University of Nevada, Reno, Washoe County, and the Western Regional Water Commission.The Reno area doesn't have a history of threatened water supplies, and historic snowfall this past winter eased drought conditions in Nevada and across parts of the Mountain West. But that could shift quickly with climate change.To stay updated on all-things-science, sign up for Science Friday's newsletters.Transcripts for each segment will be available the week after the show airs on sciencefriday.com.

A second full episode this week for you Sinica listeners! Jude Blanchette joins to talk about the House Select Committee on United States Competition with the Chinese Communist Party, and all that is wrong with it, from its framing of the CCP as an "existential threat" to its focus on the CCP, and how all of this adds up to an embarrassing moral panic that distracts from the serious issues the U.S. confronts when it comes to China.4:37 – What's wrong with the Select Committee's framing of China as an “existential threat,” and why the first hearing was an embarrassment9:01 – The current moment as a moral panic over China12:09 – Domestic political drivers of U.S. China policy15:04 – Why the United States versus the Chinese Communist Party is the wrong framing too22:46 – Is this more like McCarthyism — or antisemitism? 28:58 – The downstream effects of U.S. tech containment policy toward China42:01 – The advantage of simplistic, Manichean messaging46:15 – Prioritizing U.S. issues with China: why Confucius Institutes and TikTok are so far down the to-do list, and what really matters48:59 – And what are the real issues that deserve priority?A complete transcript of this podcast is available at TheChinaProject.comRecommendations:Jude: Miracle and Wonder: Conversations with Paul Simon by Malcolm Gladwell and Bruce Headlam, from AudibleKaiser: This podcast interview with Angela Rasmussen, the virologist who has been in the front lines fighting back against the resurgent lab leak theory, from the Slate What Next: TBD podcastSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cases of norovirus are increasing in Canada after a pandemic lull. If you haven't had it before, it's a highly-contagious virus that causes several unpleasant symptoms. Angela Rasmussen, a virologist at the University of Saskatchewan's Vaccine and Infectious Disease Organization, shares what we know about the virus and how best to avoid it. For transcripts of this series, please visit: https://www.cbc.ca/radio/podcastnews/the-dose-transcripts-listen-1.6732281

Today's guests: Sam Cooper, investigative journalist - Global News Dr. Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan Dr Dale Whelehan, behavioural scientist and CEO of 4 Day Week Global Learn more about your ad choices. Visit megaphone.fm/adchoices

Covid-19 isn't quite done with us yet, but virologists are urging governments around the world to start preparing for the next pandemic. They warn it's just a matter of time before it happens, and with good planning lessons learned from the current response can keep us from getting caught flat-footed again. So far, though, such calls haven't been met with much enthusiasm by politicians who have more immediate concerns in front of them.  Dr. Angela Rasmussen, a virologist with the Vaccine and Infectious Disease Organization at the University of Saskatchewan, joins this episode to explain where the next virus is likely to come from, and how to get in front of it. And Bloomberg reporters Riley Griffin and Josh Wingrove talk about what governments learned from covid pandemic–and what if anything they're doing to brace for what's to come. Read more about this story HERE. Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK  Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.See omnystudio.com/listener for privacy information.

The XBB 1.5 variant of COVID is quickly becoming the dominant strain in the US, and we're seeing more cases here in Canada too. The WHO has called it the most transmissible variant of the virus we've seen so far.Some people are calling it ‘The Kraken.' But not Dr. Angela Rasmussen. She's a virologist at VIDO, the Vaccine and Infectious Disease Organization at the University of Saskatchewan, and she'll walk us through what we know about this variant, what we don't know, and how concerned we should be.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com

GUEST: Dr. Angela Rasmussen on COVID, RSV and flu // Ursula Reutin, Spike O'Neil, Lisa Brooks, Nick Creasia and Aaron Mason cover "Little Drummer Boy." // WE HEAR YOU! and WORDS TO LIVE BYSee omnystudio.com/listener for privacy information.

Join expert SB Pye and guests Tania Lintz and Hannah Trettenero for a deep dive on virus outbreaks, and why some new viruses spread like wildfire while others peter out. You can download this paper on our website here. If you liked this episode and want to learn more about viruses, you can send questions to SB at e.pye@wustl.edu, or submit them via the Continue the Conversation tab on our website! You can also check out virologists Dr. Angela Rasmussen, Dr. Benhur Lee, and Trevor Bedford on Twitter. For more virology podcasts, check out This Week in Virology and This Podcast Will Kill You. Remember to follow In Plain English on Facebook , Twitter, and Instagram to keep up with the latest announcements! If you are able, please consider becoming a Patron to help support In Plain English! And check out our Where to Listen page to subscribe to our podcast on your favorite platform! Photo Credit: Corona Virus Spreading Across City Concept. 3D Rendering Aerial View Miniature City Buildings" by maggie_talal is licensed under CC BY-SA 2.0

Dr. Angela Rasmussen joins Daniella to talk about the “tripledemic;" the trio of COVID-19, flu, and RSV viruses that are on the rise in the U.S. They discuss what to expect from these three health threats, protests in China over the country's pandemic response, and ways people can best keep their loved ones safe this winter. Daniella also discusses former President Donald Trump's dinner with Ye and white supremacist Nick Fuentes, and the upcoming Georgia runoff election.

Since the Covid-19 pandemic began, scientists studying the virus have become targets of online harassment, and more recently, death threats. Roland speaks to Dr Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan, about her experiences. Spyros Lytras, PhD candidate at the University of Glasgow, talks Roland through the evolutionary history of the virus that causes Covid-19 and how there isn't just one ancestor, but several. Anti-Asian sentiment has seen a big increase since the pandemic. Dr Qian He, Postdoctoral Research Associate at Princeton University, looked into how US-China relations have influenced how Americans view Chinese today. And we hear from scientists on board the RRS Discovery, which is currently located near St Helena and Ascension Island, surveying the health of the surrounding ocean. On board documentary filmmaker Lawrence Eagling talks to Shona Murray, pelagic ecologist from the University of Western Australia, and Gareth Flint, mechanical engineer at British Antarctic Survey, about their work and findings. Why don't we fall out of bed when we're asleep? That's the question that's been keeping CrowdScience listener Isaac in Ghana awake, and presenter Alex Lathbridge is determined to settle down with some experts and find an answer. Once our sleep experts are bedded in, we'll also be wondering why some people laugh in their sleep, why others snore and how some people can remember their dreams. And Alex takes a trip to the zoo to meet some animals that have very different sleep patterns to humans. It's his dream assignment. (Image credit: Getty Images)

Since the Covid-19 pandemic began, scientists studying the virus have become targets of online harassment, and more recently, death threats. Roland speaks to Dr Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan, about her experiences. Spyros Lytras, PhD candidate at the University of Glasgow, talks Roland through the evolutionary history of the virus that causes Covid-19 and how there isn't just one ancestor, but several. Anti-Asian sentiment has seen a big increase since the pandemic. Dr Qian He, Postdoctoral Research Associate at Princeton University, looked into how US-China relations have influenced how Americans view Chinese today. And we hear from scientists on board the RRS Discovery, which is currently located near St Helena and Ascension Island, surveying the health of the surrounding ocean. On board, documentary film-maker Lawrence Eagling, talks to Shona Murray, pelagic ecologist from the University of Western Australia, and Gareth Flint, mechanical engineer at British Antarctic Survey, about their work and findings. (Photo: A scientist stands behind testing kits and checks his phone. Credit: Getty Images) Producer: Roland Pease Assistant producer: Sophie Ormiston

WHAT'S NEW AT 10! with GUEST: Dr. Angela Rasmussen on monkeypox// GUEST: Heather Bosch with the amazing story of a retiring teacher who inspired a million popular cartoons // SCENARIOS!See omnystudio.com/listener for privacy information.

A virologist at the University of Saskatchewan is using statistics to determine the origins of COVID 19. Was it a lab spill or a bat at a wet market? Understanding ‘gain of function' research with VIDO's Dr. Angela Rasmussen on this week's No Nonsense.

We spoke with study co-author Dr. Angela Rasmussen, Virologist with the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan

From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organization, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organization, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organization, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organization, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

WHAT'S NEW AT 10! with GUEST: Dr. Angela Rasmussen on monkeypox, BA.5 and vaccines // King Country Council approves creation of permanent gun, ammo return program // SCENARIOS!See omnystudio.com/listener for privacy information.

From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organization, joins William Brangham to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Guest host Helen Mann speaks with virologist Angela Rasmussen about what lessons and measures we need to employ during a new surge of COVID cases, a look at how the B.C. Wildfire Service is keeping firefighters safe and healthy, and Jaivet Ealom recounts his experience escaping one of Australia's notorious offshore detention centres. Tell us what you think of our podcast by filling out this short survey: https://www.cbc.ca/1.6498021

WHAT'S NEW AT 10! //  GUEST: Dr. Angela Rasmussen on monkeypox // SCENARIOS See omnystudio.com/listener for privacy information.

Omicron is still the dominant coronavirus strain in the country. But lately we've been hearing about what's been dubbed the “little sister” of Omicron, known as subvariant BA.2. So what do we know about this Omicron subvariant? We find out from Angela Rasmussen, a virologist at the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO).

Angela Rasmussen, research scientist at the vaccine and infectious disease organization (VIDO) at the university of Saskatchewan and affiliate at the Georgetown Global Health Science & Security, joins to discuss the latest in COVID-19 news headlines, plus your calls.

Guest: Dr. Angela Rasmussen on Covid & Omicron // AGREE TO DISAGREE // ASK GEE ANYTHING! and WORDS TO LIVE BY See omnystudio.com/listener for privacy information.

Today's guests: Dr. Angela Rasmussen, virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan Emmett Macfarlane, associate professor in the Department of Political Science at the University of Waterloo / editor and contributor: "Dilemmas of Free Expression" Ivonne Martinez, president of the Alberta Liquor Store Association Kevin Donovan, Chief Investigative Reporter, Toronto Star / author - "The Billionaire Murders"  See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers your questions about the Omicron variant and booster shots // Violence rises in South King County, local mayors are taking action / Retail theft and burglaries // Does social media pressure teens to steal to keep up? See omnystudio.com/listener for privacy information.

We spoke with Dr. Angela Rasmussen, research scientist - Vaccine and Infectious Disease Organization (VIDO), adjunct professor in the Department of Biochemistry, Microbiology, and Immunology at the University of Saskatchewan, and affiliate - Georgetown Center for Global Health Science and Security See omnystudio.com/listener for privacy information.

The COVID-19 pandemic has upended our systems and consumed our attention since March 2020. Unfortunately, the other pathogens didn't go away and, in some ways, we're given a new chance to thrive. Patient beds were taken out of the known environments and pushed to the hallway so overworked hospital staff could care for a nonstop influx of patients. PPE and cleaning products were in short supply, so EVS made decisions on the fly about alternative cleaning solutions and methods. The industry did the best it could under the circumstances. Mistakes were made. Approvals were reversed. Confusion ensued. It turns out, as John LaRochelle puts it: “You can't just throw labor at the problem”. There were bright spots too. GBAC designed and launched its GBAC Star Accreditation program during the pandemic and has helped scores of hotels, stadiums, convention centers and more reopen their facilities safely. The public became educated in key public health issues that we could never have gotten them to think about in the past, creating wonderful opportunities to expand our dialogue and improve public safety going forward. And though it was often painful, we learned important messages about how to better communicate science to the public. All of this sets the stage for the cleaning industry's big return to in-person events at the ISSA Show 2021 in Las Vegas from November 15-18, 2021. This event is an opportunity for the best minds in the cleaning industry to come together, take stock of the past 18+ months, and regroup on priorities for 2022.   To help you get ready for the show, we're talking with TIPS board members John LaRochelle and Dr. Rodney E. Rohde. John and Dr. Rohde provide an overview of where the pandemic has led the cleaning industry and they identify key issues that need our attention while we continue to grapple with COVID-19. You can also check out John LaRochelle and Dr. Rodney Rohde (along with Daniel Gordon) speaking at the ISSA Show! They are presenting Post-Pandemic: The Truth About What Really Works in Hospitality on Tuesday, November 16, 2021, from 1-2 PM at Location: W205-W206. If you're headed to the ISSA Show then this episode will get you primed and ready to make the most of it. And even if you're not, it's full of expertise and insights that will help you plan for a productive 2022. ... Complementary listening to expand on the topics discussed throughout this episode:   How to Ensure We Are Ready for the Next Pandemic with Patty Olinger Using the COVID-19 Shared Experience to Make Public Health Communication More Effective with Vanessa Lamers Supporting the Front-lines and Improving Communication During a Pandemic with Dr. Saskia Popescu Overcoming Emergent Problems in a Deepening Crisis with Dr. Angela Rasmussen   For links and show notes, visit: https://deepdive.tips

Fact Check My Feed: More Kids Can Get COVID-19 Vaccines. Now What? Many parents around the U.S. breathed a sigh of relief—or an even more intense emotional reaction—at the long-awaited news that the Centers for Disease Control and Prevention (CDC) had signed off on advising the Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11 this week. The recommendation came after a unanimous vote from the agency's committee of outside vaccine experts. And last week, the Food and Drug Administration (FDA) authorized the shot after a review of clinical trial data found both low risk and high efficacy in a smaller, kid-calibrated dose of the vaccine. University of Saskatchewan virologist Angela Rasmussen joins Ira to look at the data behind the FDA's long-anticipated decision. They also discuss the rationale behind booster shots for high-risk adults, what it means that deer in Iowa have been caught transmitting the virus, COVID-pragmatic holiday planning, and other pandemic news.   In First Real-World Experiment, Red Seaweed Cuts Methane In Cows By More Than Half Methane emissions are a hot topic—largely because it's a big contributor to climate change. Methane makes up about 10% of human-caused greenhouse gas emissions. 27% of that comes from the burps of ruminant animals, such as cows. In April, Science Friday did a story about research that showed promising results when steers were fed small amounts of the red algae Asparagopsis in their diets. At the time, these experiments were only done in a closely controlled university setting. Now, the first real-world study on a working dairy farm has been completed. The results? Methane released by the seaweed-eating cows was 52% less on average than their non-seaweed-munching counterparts. Coming on the heels of the Biden administration's methane emissions reduction plan, SciFri producer Kathleen Davis sits down with three key players in this milestone: Joan Salwen, CEO of Blue Ocean Barns in Kailua-Kona, Hawaii, the company that produces the Asparagopsis seaweed powder; Dr. Breanna Roque, animal science consultant at Blue Ocean Barns in Townsville, Queensland, Australia; and Albert Straus, founder and CEO of Straus Family Creamery in Marshall, California.   The Science Friday Theme Song That Got Lost In The Mail Back in 1998, comedian and author Steve Allen, first host of The Tonight Show, joined Ira on Science Friday to talk about the importance of critical thinking. Allen had written a book called Dumbth, calling for improvements in the public's logical reasoning abilities. Ira was a longtime fan of Allen's, and eagerly invited him to discuss the book. During the interview, Allen also took to the studio piano to play his signature song, “This Could Be The Start of Something Big.” As the comedian was leaving, Ira jokingly remarked that Science Friday could use a theme song of its own. Several years later, while cleaning the cluttered SciFri office, staff uncovered an unopened box of mail—including an envelope from Hollywood containing a single cassette tape, marked “Theme Song For Science Friday—Steve Allen.” As part of Science Friday's 30th anniversary celebrations, Ira and SciFri director Charles Bergquist recount the story of the tape, and finally premiere the song, written and performed by the late Steve Allen.      

GUEST: Dr. Angela Rasmussen answers questions on the COVID vaccines for kids 5-11 // U.S. women are largely dissatisfied with how they're treated. Most men don't // SCENARIOS See omnystudio.com/listener for privacy information.

Virologist Angela Rasmussen listened to a recent Canadaland about the origins of COVID-19 and says we had it all wrong. Today she walks Jesse through the science and explains why the lab-leak theory remains highly improbable, what she feels previous guest Elaine Dewar got wrong, and how journalists should cover science during a pandemic and otherwise.  Further Reading: The origins of SARS-CoV-2: A critical review, by Dr. Angela Rasmussen, et al.  Sponsors: Kilne, Douglas, Squarespace Support CANADALAND: http://canadalandshow.com/join See omnystudio.com/listener for privacy information.

In late September, the World Health Organization announced that it had assembled a new team of scientists to revive its investigation into the origins of the virus that causes Covid-19. The new group will be tasked with examining whether the virus could have originated in a lab, months after its predecessor deemed the possibility too unlikely for serious consideration.This week on Intercepted: Intercept investigative reporters Sharon Lerner and Mara Hvistendahl join editor Maia Hibbett to discuss the competing theories on the origins of Covid-19. The Intercept obtained documents that shed new light on controversial lab experiments, raising questions about the origins of the coronavirus pandemic. With neither of the main theories -- natural spillover versus a lab leak -- yet proved true, the Intercept is seeking answers as to how much officials knew about proposed behind-the-scenes experiments. As Georgetown virologist Angela Rasmussen, a staunch critic of the lab-leak theory, said after the first WHO investigation, “There are still major stones that need to be unturned.” See acast.com/privacy for privacy and opt-out information.

GUEST: Dr. Angela Rasmussen on the Seattle woman who died after taking the J&J vaccine and more // The Forbes 400 list is out. . . and the richest Americans became 40% richer during the pandemic // SCENARIOS See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers our COVID questions // ‘Stalkerware' Apps Are Proliferating // WE HEAR YOU! and WORDS TO LIVE BY See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers listener questions about vaccine boosters and a Pfizer vaccine for kids // The search for missing 21-year-old Gabrielle "Gabby" Petito may be over with the discovery of remains at a Wyoming campsite, but now her fiancé has vanished // SCENARIOS See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers our COVID questions about BOOSTERS // GUEST: Jenna, a nurse at Evergreen hospital in Kirkland on whether it's “really that bad” at hospitals right now // SCENARIOS See omnystudio.com/listener for privacy information.

Today's guests: Andrew Coyne, columnist - Globe & Mail Rachel Notley, Official Opposition Leader / NDP Leader / Former Premier Dr. Angela Rasmussen, Virologist - Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan Alan Cross, Music writer/broadcaster/historian / Host  - The Ongoing History of New Music See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers our COVID questions about why people who've had COVID should be required to get vaccinated, Ivermectin, the new Mu variant, etc. // GUEST: Bruce Harrell talks Compassion Seattle, the homeless encampment at Greenlake // SCENARIOS See omnystudio.com/listener for privacy information.

GUEST: Dr. Angela Rasmussen answers our COVID questions // The baby on Nirvana album cover is suing the band 30 years later // SCENARIOS See omnystudio.com/listener for privacy information.

Requiring proof of vaccination isn't a novel idea. Schools across the United States require students to get certain vaccinations before the age of 6. You need a yellow fever vaccine to travel to parts of Africa and South America. Now, with a global pandemic, the conversation has shifted to Covid vaccination requirements.With little more than 50 percent of the United States fully vaccinated against Covid-19, and the Delta variant leading to increased case counts, it's no surprise that our focus has shifted to vaccine mandates. This week, the Pfizer-BioNTech vaccine was granted approval by the Food and Drug Administration, which likely means more mandates and boosters.Cities like New York and San Francisco already have mandates in place, for accessing indoor dining, gyms and concerts. But do these requirements really help those on the fence? Will the F.D.A.'s declaration sway the roughly 30 percent of Americans who said they'd be more likely to get the vaccine after it was fully approved? Or will it just alienate an entire population of people already hesitant to get the vaccine?In this episode, Jane Coaston and her guests discuss the benefits and risks of vaccine mandates. Angela Rasmussen is a virologist at the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan. And Marcella Tillett is the vice president of programs and partnerships at the Brooklyn Community Foundation, an organization that's helping those in the area get vaccinated.Mentioned in this episode:“Do Mandatory Vaccines Violate Human Rights?” published in Quartz“Everybody I Know Is Pissed Off” in The Atlantic, which gathers together some of the latest polling on vaccine mandates.(A full transcript of this episode will be available midday on the Times website.)

GUEST: Dr. Angela Rasmussen answers our COVID questions // GUEST: Chris Sullivan says the END IS NEAR! Construction on I-5 in Tacoma will be DONE in just a few months // SCENARIOS See omnystudio.com/listener for privacy information.

THREE THINGS YOU NEED TO KNOW // GUEST: Dr. Angela Rasmussen answers our COVID questions // Today's Teens Are in No Rush to Start Driving. Why? Is this a problem? Is this a sign of today's kids being too dependent on their parents? // SCENARIOS See omnystudio.com/listener for privacy information.

As the delta variant rages on, we speak with PPR friend + client Dr. Angela Rasmussen about her meteoric rise to media fame on the heels of the pandemic. She shares with us the good, the bad and the ugly about being in the media spotlight. Science writer Tara Haelle also drops by and she fills us in on the process of fact-checking when it comes to in-depth scientific pieces. She also offers great tips for publicists looking to pitch her!

Dr. Angela Rasmussen, Researcher at the Vaccine and Infectious Disease Research Organization – International Vaccine Centre (VIDO-InterVac) joins Dr. Marc Siegel and discusses vaccine approvals, COVID immunity, Delta Variant transmission and the surge of infections in the US.

URSULA'S TOP 5 // GUEST: Dr. Angela Rasmussen on the danger of Delta and new info from the CDC // WE NEED TO TALK about what's bringing us joy See omnystudio.com/listener for privacy information.

THREE THINGS YOU NEED TO KNOW // GUEST: Dr. Angela Rasmussen explains the Delta COVID variant that's rampaging through India, killing 6,000+ per day. (It's both more transmissible AND more deadly). And why people who either haven't had their second shot, or took the J&J vaccine may want to get another shot soon // SCENARIOS See omnystudio.com/listener for privacy information.

THREE THINGS YOU NEED TO KNOW // GUEST: Dr. Angela Rasmussen answers our COVID questions -- including why we probably don't need to talk to her every week anymore // SCENARIOS See omnystudio.com/listener for privacy information.

THREE THINGS YOU NEED TO KNOW // GUEST: Dr. Angela Rasmussen answers our COVID questions about the 18 year old who developed a heart condition after getting his 2nd vaccine // SCENARIOS See omnystudio.com/listener for privacy information.

Angela Rasmussen, virologist, research scientist at the Vaccine and Infectious Disease Organization (VIDO) and affiliate at the Georgetown Center for Global Health Science and Security, answers listeners' questions about the COVID vaccines and immunity to the virus.  

THREE THINGS YOU NEED TO KNOW: ESD arrest (with Heather Bosch), Inlsee vetoes (with Hanna Scott), and local health officials want you to keep your mask on // GUEST: Dr. Angela Rasmussen on whether the CDC jumped the gun on telling vaccinated people to take off their masks // SCENARIOS See omnystudio.com/listener for privacy information.

TOP 3 THINGS YOU NEED TO KNOW // GUEST - Dr. Angela Rasmussen // SCENARIOS!  See omnystudio.com/listener for privacy information.

Angela Rasmussen, PhD, research scientist at the Vaccine and Infectious Disease Research Organization – International Vaccine Centre (VIDO-InterVac) joins Dr. Marc Siegel and dispels the misinformation about vaccine efficacy and safety protocols.  Hear about the vaccines available globally, and why getting vaccinated  is necessary even if you've already had COVID.

Weighing COVID-19 Vaccinations For Teens Federal officials are reporting that the Food and Drug Administration is poised to authorize Pfizer’s COVID-19 vaccine for children ages 12 to 15 by early next week—just as Canada became the first country to do so on Wednesday of this week. Pfizer has said they will seek out emergency authorization for even younger kids by the fall. But as most countries still lag far behind the United States in vaccine access for adults, public health officials are questioning the ethics of prioritizing American teens over adults from other countries. Science writer Maggie Koerth joins Ira with more on the accessibility of COVID-19 vaccines for children, new projections of rapid sea level rise under climate change, and other stories from the week. Is COVID-19 Herd Immunity Even Possible Anymore? Since the start of the pandemic, we’ve equated getting out of this mess with the concept of herd immunity—when a certain percentage of the population is immune to a disease, mostly through vaccination. With COVID-19, experts have said we need somewhere around 70 to 90% of the population to be immunized to meet this goal. Now that all adults in the U.S. are eligible for the vaccine, how far are we from that goal? And what is our trajectory? Some experts now say with variants and vaccine hesitancy, herd immunity may not be possible here in the U.S. Joining Ira to break down this and other coronavirus quandaries is Angela Rasmussen, research scientist at VIDO-InterVac, the University of Saskatchewan’s vaccine research institute in Saskatoon, Saskatchewan. This Computer Won The 2021 American Crossword Puzzle Tournament In 2012, a computer program named Dr. Fill placed 141st out of some 660 entries in that year’s American Crossword Puzzle Tournament, a competition for elite crossword puzzle solvers. This year, the algorithm beat the human competition, completing the final playoff puzzle in just 49 seconds.  The A.I. relies on a collection of different techniques to make sense of a puzzle. Sometimes, a simple fact is needed—who was the First Lady before Eleanor Roosevelt? (Lou Henry Hoover.) More often, however, crossword puzzle solutions rely not just on factual knowledge, but an ability to recognize themes that puzzle constructors have embedded in the crosswords, along with an understanding of puns, homonyms, and word play. (Think: Five letters, “dining table leaves”—SALAD!) The program makes a series of statistical calculations about likely answers, then tries to fit those possibilities into the puzzle squares.  This year, researchers from the Berkeley Natural Language Processing group added their expertise to Dr. Fill’s algorithms—a contribution that may have helped push Dr. Fill to its crowning victory.  But the program isn’t infallible. This year, it made three mistakes solving puzzles during the tournament, while some human solvers completed the puzzles perfectly. It can make these errors with any unique puzzle form it’s never seen before.  Matt Ginsberg, the computer programmer behind Dr. Fill, joins Ira to talk about the competition and the advances his program has made over the years. 

First, STAT Washington correspondent Rachel Cohrs joins us to explain why President Biden's endorsement for drug pricing reform rang hollow to many advocates. Next, virologist Angela Rasmussen calls in to discuss the controversy around a Russian-produced vaccine for Covid-19. Finally, STAT's Kate Sheridan joins us to talk about how a shortage of cheap, little-discussed plastic tools is hobbling scientific labs around the world.

TOP 3: The CDC releases new information on mask use, Tucker Carlson has stuff to say about masks and the exodus of Seattle Police officers continue // Dr. Angela Rasmussen joins us to answer your COVID questions // SCENARIOS See omnystudio.com/listener for privacy information.

"I don't think that herd immunity is a possibility for SARS CoV-2. I think there's going to be a different kind of equilibrium that we reach in the future where humans and SARS-CoV-2 co-exist in a much milder, more benign way." -Jennie LavineThe end of the pandemic might not mean the end of SARS-CoV-2. In fact, many scientists think COVID is here to stay, even with vaccines.  In this episode we'll hear why we may never reach herd immunity, how the coronavirus could change over time, and why kids are the key to reducing the severity of the disease.This podcast was created by Just Human Productions. We're powered and distributed by Simplecast. We're supported, in part, by listeners like you.#SARSCoV2 #COVID19 #COVID #coronavirus

The big news on Covid last week was the decision by the CDC and FDA to call for a nationwide halt to delivering the Johnson & Johnson vaccine while they investigate a rare blood-clotting disorder. Our guest, Dr. Angela Rasmussen, is a virologist and one of the most well-known and oft-quoted scientists on Covid vaccines. She has written for Forbes, Foreign Affairs, Slate, the Guardian, and Leapsmag, and appeared many times in media outlets including the New York Times (including an op-ed last week), the Washington Post, National Public Radio, ABC, NBC, CNN, CBC, and BBC. And last week, she appeared in a really good explanatory article on the Johnson and Johnson vaccine by Katherine Wu in The Atlantic. So we invited her to walk us all through what we need to know about the J&J pause and the fight against Covid in general.

As COVID vaccines become more accessible to the public, it's important to keep in mind the present dangers of other common respiratory illnesses. Transmission of these infections affects everyone, from Baby Boomers to Gen Zers, in various ways that could be fatal for some but a cough to others. Dr. Angela Rasmussen joins us to discuss testing and transmission regarding influenza, respiratory syncytial virus (RSV), and COVID-19. Hosted by: Silvia Quevedo, CAE About our Guest: Angela L. Rasmussen, Ph.D Angela L. Rasmussen, Ph.D. is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Dr. Rasmussen will also be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), a vaccine research institute at the University of Saskatchewan. Dr. Rasmussen is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens. Dr. Rasmussen studies the role of the host response in emerging virus pathogenesis, with a particular interest in viruses that are or have the potential to be major threats to global health, such as influenza, dengue, Ebola, MERS-CoV, and SARS-CoV-2.

Podcast: On Point (LS 65 · TOP 0.1% what is this?)Episode: From Variants To Vaccines: The Future Of COVID-19Pub date: 2021-02-23Vaccine distribution, across the U.S. and the globe, is ramping up. But new variant cases are rising in the United States, waits for the vaccine are long, and most of us just want to know -- how will this pandemic end? Tara C. Smith, Angela Rasmussen and Ananya Banerjee join Kimberly Atkins. The podcast and artwork embedded on this page are from WBUR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

As many as a dozen COVID-19 variants are knowingly circulating worldwide. Among them, B.1.1.7 and B.1.351, the highly transmissible strains that originated in the U.K. and South Africa, respectively. As more vaccines continue to push forward for emergency approval worldwide, we're still learning the effectiveness of the current vaccines against the new strains; and how the new mutations mean even those who have already had COVID-19 may not be immune from reinfection. To explore the new strains and what it means for vaccination efforts, future mutations, and herd immunity, Angela Rasmussen, PhD, a virologist with Georgetown University's Center for Global Health Science and Security, joins us on this week's episode.

The good news is the virus is retreating. The bad news is its shape-shifting in a way that might give it a new advantage. Scientists studying how SARS-CoV-2 is evolving within individual patients figured out why it's mutated faster, and with greater consequence, then they anticipated last summer. Will vaccines be able to keep up? “Follow the Science" is produced, written, and hosted by Faye Flam, with funding by the Society for Professional Journalists. Today's episode was edited by Seth Gliksman with music by Kyle Imperatore. If you'd like to hear more "Follow the Science," please like, follow, and subscribe!

It's been five months since the Labor Day fires ripped through Oregon's Santiam Canyon and residents are still in recovery mode. Angela Rasmussen is the principal of Santiam Junior/Senior High School. After the devastating fires, she set up a fund to raise money for students who lost so much. While most of their basic food and shelter needs are met, many lost personal possessions and a sense of safety. We talk with Rasmussen about her efforts to help students.

The COVID-19 pandemic continues to worsen by most objective measures. We're breaking records for cases, deaths, and hospitalizations on a regular basis, and many of our hospitals are operating at or near capacity. Further complicating the situation, scientists are tracking the “UK variant” that is more transmissible, and our vaccine distribution has fallen well short of expectations. Emergent problems in a deepening crisis, of course, make us vulnerable to knee-jerk reactions that distract us from the known path to getting the pandemic under control. On this episode, we're talking with virologist Dr. Angela Rasmussen about these emergent issues. She helps us to understand what they mean and puts them in context by pointing out the good things that are happening too. First and foremost, the vaccines are more efficacious than expected (i.e., around 95%). Second, the “UK variant”, while worrisome, has not evolved in any way that makes existing, non-pharmaceutical interventions less effective (e.g., masks, social-distancing, avoid crowds, clean high-touch surfaces, etc.).   The UK Strain Dr. Rasmussen tells us that the B.1.1.7 strain, better known as the “UK variant”, is worrisome. However, travel bans aren't an effective response to the new COVID-19 variant. The new strain was detected first in the UK, but that is likely because the UK is doing more genomic surveillance than most countries. They found it because they were looking, but it could have originated elsewhere. Dr. Rasmussen explains “travel bans are only really effective when you can guarantee that you would not be exporting the virus from one place to another”. And since we don't know for sure where the variant first-evolved, or where it has spread to, there is simply no way to design an effective travel ban. We also discuss:   How viruses mutate and evolve Why the new variant is believed to be more transmissible Potential behavior components that may have impacted the numbers That the known, non-pharmaceutical interventions work against every variant of SARS coronavirus (i.e., the virus hasn't mutated in a way that makes our masks, social-distancing, etc. less effective). We should double-down on those now.   Communicating Science to the Public We continue to examine communications lessons that can be learned from the COVID-19 pandemic. Dr Rasmussen tells us that scientists and media tend to make one of two mistakes:   They default to the worst case scenario and communicate in a very reactionary way They oversimplify things, trying to get the public to understand and comply with certain behaviors   Both approaches create gaps in understanding and acceptance of our message. To mitigate these issues, Dr. Rasmussen tells us to think about three key things whenever we're communicating science to the public:   Talk openly about what we don't know, and about the nuances, so that people become more comfortable with uncertainty End every message with actionable advice. Tell them what they can and should do right now to protect themselves. Repeat the message over and over. In a constantly evolving environment, we may be tempted to jump from topic to topic. Our messaging should always be grounded in the tried and true (e.g., the non-pharmaceutical interventions discussed earlier)   Vaccine Challenges We're dealing with a triple threat when it comes to the vaccine. First, we have our current distribution problems. There are vaccines available and they are being administered much more slowly than we'd like. Second, there are known supply challenges that could worsen if/when we alleviate the distribution delays. Third, we're dealing with vaccine “hesitancy” and the recent discussions around changing dosing regimens, despite the fact that we have no data to support those changes, might cast further doubt for those on the fence. Dr. Rasmussen shares her thoughts on these high-level issues, and gets into the details of each:   What is causing our distribution problems, and what are the steps that can be taken right now? What do we know about the potential for widespread supply issues, and how are our current efforts to head them off distracting us from the distribution problem we have right now? What will it take to achieve herd immunity and slow, or stop community transmission? Why the vaccine is a medium-to-long-term solution, and the importance of redoubling our efforts on non-pharmaceutical interventions to slow community spread in the near-term How we can use the tried-and-true epidemiological path, in conjunction with vaccination to slow community transmission and get us on the right path in the foreseeable future   Dr. Angela Rasmussen Dr. Rasmussen is a virologist studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing. She is particularly interested in viruses that are highly pathogenic, newly emergent or likely to emerge because of climate change, land development, or ecological disruption. Currently she is focused on SARS-CoV-2, as well as other emerging pathogens with the potential to profoundly impact global health, such as Ebola virus, MERS-CoV, influenza virus, and hemorrhagic fever viruses. She works closely with other faculty and affiliates within the GHSS on the Viral Emergence Research Initiative (the VERENA Consortium), where she leads the core virology team. Dr. Rasmussen has employed uses in vitro systems, animal models, and clinical specimens to study the relationship between host response and pathogenesis. She previously developed a  model of Ebola virus disease in a genetically diverse panel of mice, the Collaborative Cross (CC), leveraging the diversity of CC mouse disease phenotypes to study genetic and transcriptomic factors underlying disease severity in humans. She has applied this model to developing predictive signatures of disease outcome and infection and identify novel drug targets. She is currently evaluating CC mouse models towards investigation of sex-specific host responses to viral infection, as well as to investigate disease presentation in other viruses that pose a major threat to global public health, including SARS-CoV-2. Ultimately, these host response profiles can be used for translational or biodefense applications, such as diagnosing infection, predicting disease severity, informing vaccine design, and developing or repurposing host-targeted drugs to impair virus replication or reverse pathology.  Dr. Rasmussen has published numerous original research articles in the peer-reviewed literature and serves on the editorial board of Cell Reports and mSphere. In addition to her scientific work, she believes that engagement of the public is essential to successful public health initiatives and is an active and outspoken science communicator. She has written for Forbes, Foreign Affairs, Slate, the Guardian, and Leapsmag, and appeared many times in media outlets including the New York Times, the Washington Post, National Public Radio, ABC, NBC, CNN, CBC, and BBC. She is also an advocate for equitable and inclusive science, and serves on the NIH Advisory Committee to the Director's Working Group on Changing the Culture to End Sexual Harassment.   Email: ar1692@georgetown.edu Web: https://angelarasmussen.org/ Twitter: @angie_rasmussen   Links and Resources   For mRNA vaccines, we should stick to the schedule Travel bans aren't an effective response to the new COVID-19 variant Pizza-sized boxes and paying a premium: Israel's COVID-19 vaccine rollout Canada has secured more vaccine doses per capita than anyone else, but it's been slow to administer them Doug Ford says Ontario will run out of Pfizer COVID-19 vaccines by end of next week

UK investigators are looking into reports of coronavirus vaccine recipients having allergic reactions. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security says it may take a while before we know the allergic reactions are linked to the vaccine.Many of us may be tired of wearing facial coverings, but Dr. Chris Colbert from the Emergency Medicine Residency Program at the University of Illinois/Chicago says it'll take at least an year before we can interact with others without face masks. President-elect Joe Biden has announced set of plans to combat the pandemic, including a possible national mandate on facial coverings. Dr. Peter Katona from UCLA's Geffen School of Medicine offers "cautious optimism."A California small business-owner is keeping her café doors open by designating the patio area as "protest zones" to work around the State government's outdoor dining ban. Tricia Neal, who owns the Swork coffee shop in Eagle Rock, CA, says, while she doesn't blame health officials, the outdoor dining ban has been hard on her business.Americans are desperately in need of financial assistance from the second COVID relief bill. But what's holding it up in Congress? Rep. Katie Porter (D-Calif.) says Senate Majority Leader Mitch McConnell is to be blamed.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

UK investigators are looking into reports of coronavirus vaccine recipients having allergic reactions. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security says it may take a while before we know the allergic reactions are linked to the vaccine. Many of us may be tired of wearing facial coverings, but Dr. Chris Colbert from the Emergency Medicine Residency Program at the University of Illinois/Chicago says it'll take at least an year before we can interact with others without face masks.  President-elect Joe Biden has announced set of plans to combat the pandemic, including a possible national mandate on facial coverings. Dr. Peter Katona from UCLA's Geffen School of Medicine offers "cautious optimism." A California small business-owner is keeping her café doors open by designating the patio area as "protest zones" to work around the State government's outdoor dining ban. Tricia Neal, who owns the Swork coffee shop in Eagle Rock, CA, says, while she doesn't blame health officials, the outdoor dining ban has been hard on her business. Americans are desperately in need of financial assistance from the second COVID relief bill. But what's holding it up in Congress? Rep. Katie Porter (D-Calif.) says Senate Majority Leader Mitch McConnell is to be blamed.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Can too much Covid-19 vaccine be a bad thing? Is biotech in a bubble? And how do you make blind mice see again?

COVID-19 strikes close to home for one family after one person spread the virus to multiple family members. Pfizer has updated its data on its coronavirus vaccine, saying it's now showing a 95% effectiveness rate. Dr. Peter Hotez from the Baylor College of Medicine in Houston explains what the latest findings mean.A Danish study questions the effectiveness of face masks. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security explains.Google Maps has a new feature called the COVID Layer, which provides real-time data on the coronavirus.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

COVID-19 strikes close to home for one family after one person spread the virus to multiple family members.  Pfizer has updated its data on its coronavirus vaccine, saying it's now showing a 95% effectiveness rate. Dr. Peter Hotez from the Baylor College of Medicine in Houston explains what the latest findings mean. A Danish study questions the effectiveness of face masks. Dr. Angela Rasmussen from the Georgetown Center for Global Health Science & Security explains. Google Maps has a new feature called the COVID Layer, which provides real-time data on the coronavirus.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

The number of people infected with SARS-CoV-2 is rising in almost every state. America averaged over 100,000 new cases every day over the last seven days and 1,000 deaths every day over the same period. The positivity rate is more than 50 percent in some states, straining hospital systems and front line staff. Have we normalized the pandemic to the point where we're no longer taking it seriously enough? Also this hour: President Trump will no longer be protected from federal and state prosecution for questionable business and tax dealings when he exits the office of the presidency. There are also several civil lawsuits, including from two women who have filed separate civil suits for defamation after he denied their allegations of sexual assault. How legally vulnerable is President Trump? GUESTS: Dr. Angela Rasmussen is a virologist and an affiliate at the Georgetown Center for Global Health Science and Security. She’s a contributor to Slate (@angie_rasmussen) Ross Garber is a lawyer specializing in political investigations and impeachment and a legal analyst for CNN. He teaches at Tulane Law School. (@rossgarber) Support the show: http://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

A conversation with Columbia University virologist Angela Rasmussen on covering the pandemic.

American virologist Angela Rasmussen of the Immunity at the Columbia University School of Public Health discusses researching medical advances to end the pandemic. 

Columbia University virologist Angela Rasmussen on what we've learned so far about the coronavirus, and the many questions that still remain.

Julian Emanuel, BTIG Chief Equity & Derivatives Strategist, says sellers are exhausted and a bottoming process is starting. Angela Rasmussen, Columbia University Virologist, says opening back up parts of the U.S. economy is a bad idea without further virus testing. Randall Kroszner, Former Federal Reserve Board Member, says the Fed's actions have been crucial in avoiding a financial crisis so far. Bob Crandall, Former AMR Corp. President, CEO & Chairman, says the government needs to make a public investment in the airline industry in order to keep it functional. Leland Miller, China Beige Book CEO, says the idea of a full economic recovery any time soon is nonsense. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

In this week's bonus episode we talk to Dr Angela Rasmussen (@angie_rasmussen), a Virologist at Columbia University. She answers top questions surrounding COVID-19 and what this outbreak could mean for our future. Does genetics or blood type may affect the virus? How does the virus actually work and how do we test for it? Get a fuller picture of the virus, what we know so far, and how we can prevent this happening again.

Dr. Angela Rasmussen is an associate research scientist in the Center for Infection and Immunity at Columbia University Mailman School of Public Health. Her research focuses on how hosts respond to infection by viruses in order to determine the severity of the infection and outcomes of the disease, as well as to look for new pathways to treat the disease and how to design vaccines. She is especially interested in newly emerging viruses, such as COVID-19. Listen to the podcast to hear her explain: where COVID-19 testing stands right now and what needs to happen to improve testing some measures that people who are undergoing chemotherapy or other immunosuppressing treatments might take to protect themselves how handwashing removes the COVID-19 virus membrane some of the myths surrounding COVID-19 and why they're untrue Running time: 30:34